News

Discover practical strategies for enhancing efficiency, focusing on workflow optimization, teamwork, and clinician well-being for better patient care.

Scott Jackson, MD, explores complex drug-induced skin reactions, emphasizing diagnostic challenges and the importance of thorough medication reviews for effective treatment.

Catch up on coverage from the first day of the 2025 Fall Clinical Dermatology Conference for PAs and NPs held in Orlando, Florida.

At a recent Dermatology Times Case-Based Roundtable event, Michael Gold, MD, explored innovative vitiligo treatment strategies through complex cases and emerging therapies.

In her presentation at Fall Clinical NP/PA, Heather Gates, PA-C, shared how professionals can enhance their practice using AI and social media, fostering authenticity and patient trust in a digital age.

Lauren Miller, PA-C, MPAS, highlights the vital role of mentorship in dermatology, emphasizing its impact on professional growth and patient care at the Fall Clinical conference.

Jamie Restivo, PA-C, a board-certified dermatology physician assistant and current president of the Pennsylvania Dermatology Physician Assistants (PDPA), gave insights into the PA perspective.

Explore the latest insights in dermatology at the Fall Clinical PA/NP Conference, featuring experts like James Del Rosso, DO, and networking opportunities for PA NPs.

Discover expert insights and practice management tips at the Fall Clinical PA/NP Conference in Orlando, featuring top dermatology professionals.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Learn more about the in-depth topics covered in the May 2025 print issue of Dermatology Times.

Explore the top headlines of the week including insights on regulatory updates, expert pearls, and more.

Explore the latest insights, strategies, and treatments for patients with skin cancer as Dermatology Times looks back on Melanoma and Skin Cancer Awareness Month.

Dermatology Times is looking back on the top stories in dermatology from the month of May.

Shannon Humphrey, MD, leads a shift in aesthetic dermatology towards patient empowerment and self-care, supported by Merz Aesthetics' Pillars of Confidence study.

Jonathan Silverberg, MD, PhD, MPH, talks about when and how to take itch into consideration when choosing a therapy for AD.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Amanda Caldwell, MSN, APRN-C, is fostering community and collaboration for NPs and PAs as the new president of the SDNP.

Renata Block, PA-C, speaks with patient advocate Brittanny Groover on her experience, how to educate young patients, and understanding the psychosocial impact of melanoma.

RAPIDS 2025 captivated with expert insights on immuno-dermatology, featuring engaging sessions and lively panels.

Peter Graylin shares his transformative skin cancer journey, emphasizing the importance of early detection, sun safety, and accessible dermatology programs.

Jonathan Silverberg, MD, PhD, MPH, shares pearls from the ADvocate1 and 2 trials examining the use of lebrikizumab for AD.

A new partnership aims to revolutionize topical treatments for epidermolysis bullosa, enhancing patient care with innovative drug delivery technology.

Dermatology Times is recapping our exclusive expert interviews from the month of May.

This review of the latest dermatologic studies includes insights into psoriatic lesions and PsA, adipose mesenchymal stem cell-derived exosomes versus platelet-rich plasma, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Amanda Caldwell, MSN, APRN-C, is promoting accessibility, education, and relatability as the newly inducted president of the Society for Dermatology Nurse Practitioners.

Microneedling proves more effective than microinjections for PRP therapy in treating melasma, enhancing patient outcomes and satisfaction.

AI Medical Technology launches Dermalyser, an AI tool for melanoma diagnosis, enhancing detection accuracy and skin cancer care in Europe.

Jonathan Silverberg, MD, PhD, MPH, talks about therapies used for AD, including nemolizumab.